Literature DB >> 7959016

Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-1) in the mammary gland of transgenic rabbits.

G Brem1, P Hartl, U Besenfelder, E Wolf, N Zinovieva, R Pfaller.   

Abstract

We have developed an expression system where foreign proteins are synthesized specifically in the mammary gland of transgenic rabbits and secreted into the milk. Regulatory elements were isolated from the bovine alpha S1-casein-encoding gene and combined with a synthetic DNA coding for human IGF-1 and for [Gln58]IGF-1, an IGF-1 analogue. The resulting hybrid DNA constructs were used to generate transgenic rabbits. Females of seven transgenic lines tested were positive for synthesis of IGF-1. Transmission of the transgene to progeny and IGF-1 production in female offspring was observed in all transgenic lines analysed. As expected, expression of transgene mRNA could only be detected in the mammary gland. Production levels of transgenic protein were as high as 1 g IGF-1 per liter rabbit milk. IGF-1, as well as [Gln58]IGF-1, when secreted into rabbit milk, was correctly processed and biologically active. IGF-1 was purified from the milk of transgenic rabbits to a nearly homogenous active form.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959016     DOI: 10.1016/0378-1119(94)90175-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

Review 2.  The declining phase of lactation: peripheral or central, programmed or pathological?

Authors:  Darryl Hadsell; Jessy George; Daniel Torres
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

3.  High-level expression of bovine alpha s1-casein in milk of transgenic mice.

Authors:  M Rijnkels; P M Kooiman; G J Platenburg; M van Dixhoorn; J H Nuijens; H A de Boer; F R Pieper
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

4.  Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.

Authors:  M Uusi-Oukari; J M Hyttinen; V P Korhonen; A Västi; L Alhonen; O A Jänne; J Jänne
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

5.  Over-expression of the murine pIgR gene in the mammary gland of transgenic mice influences the milk composition and reduces its nutritional value.

Authors:  N de Groot; P van Kuik-Romeijn; S H Lee; H A de Boer
Journal:  Transgenic Res       Date:  2001-08       Impact factor: 2.788

6.  Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations.

Authors:  N Zinovieva; C Lassnig; D Schams; U Besenfelder; E Wolf; S Müller; L Frenyo; J Seregi; M Müller; G Brem
Journal:  Transgenic Res       Date:  1998-11       Impact factor: 2.788

7.  Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?

Authors:  Zuyong He; Yiqiang Zhao; Gui Mei; Ning Li; Yaosheng Chen
Journal:  Transgenic Res       Date:  2010-06-19       Impact factor: 2.788

8.  Recombinant protein expression plasmids optimized for industrial E. coli fermentation and plant systems produce biologically active human insulin-like growth factor-1 in transgenic rice and tobacco plants.

Authors:  Mitra Panahi; Zaman Alli; Xiongying Cheng; Loubaba Belbaraka; Jaafar Belgoudi; Ravinder Sardana; Jenny Phipps; Illimar Altosaar
Journal:  Transgenic Res       Date:  2004-06       Impact factor: 2.788

9.  Expression of the murine wild-type tyrosinase gene in transgenic rabbits.

Authors:  B Aigner; U Besenfelder; J Seregi; L V Frenyo; T Sahin-Toth; G Brem
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

Review 10.  The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.

Authors:  Zs Bosze; L Hiripi; J W Carnwath; H Niemann
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.